Magic Genomix is a precision oncology deeptech startup leveraging genomic instability biomarkers to persoanlize cancer treatment and de-risk drug development. Our proprietary platform, including tools like Magic X and Magic Tween, transforms complex clinical and multimodal data into clear, actionable insights.
Magic X analyzes tumor biopsy data to stratify chemotherapy response into three clinically actionable categories: predicted responders, non-responders, and patients at risk of therapy-induced harm. Magic X has demonstrated strong predictive power for chemotherapy response in retrospective soft tissue sarcoma data and is now expanding into ovarian, lung, and breast cancers with targeted and immunotherapy combinations.
With a well-defined path to regulatory approval and commercialization, Magic Genomix is committed to transforming cancer care and improving patient outcomes, one step at a time.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Harrycow 13 Rue Sainte Ursule, Magic Genomix,france
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.magic-genomix.com
- HQ
- Toulouse
Magic Genomix Questions
Magic Genomix's website is http://www.magic-genomix.com
Magic Genomix's LinkedIn profile is https://fr.linkedin.com/company/magic-genomix
Magic Genomix has
8 employees.
View email and phone details for 8
employees at Magic Genomix.
Magic Genomix's industry is
Medical and Diagnostic Laboratories
Magic Genomix's top competitors are
Infocus Therapeutics,
Betty Care,
Cyferall™,
Persea,
Made In Tracker,
Alia Santé,
Ontbo,
Le Catalyseur,
Allead,
Actipulse Neuroscience®.
Magic Genomix's categories are Medical and Diagnostic Laboratories
Magic Genomix's founding year is 2023
